Skip to main content

Advertisement

Table 2 Genetic diversity of P. vivax in patient blood samples (P) and oocysts (O) for six selected cases

From: Plasmodium vivax genetic diversity and heterozygosity in blood samples and resulting oocysts at the Thai–Myanmar border

Measure Infection Sample N Locus Mean SE
Pv3.27 Pv3.502 Pv8.504 MS5 MS6 MS7 MS8 MS16
Number of alleles Monoclonal P 3 3 3 2 2 3 3 3 3 2.750 0.164
O 97 4 3 2 2 3 3 3 3 2.875 0.227
Polyclonal P 3 4 3 2 3 3 2 4 3 3.000 0.267
O 34 5 5 4 2 6 4 6 4 4.500 0.463
All oocysts   131 7 6 5 5 6 6 8 6 6.125 0.927
Expected heterozygosity Monoclonal P 3 0.667 0.667 0.444 0.444 0.667 0.667 0.667 0.667 0.611 0.036
O 97 0.290 0.187 0.177 0.069 0.360 0.078 0.159 0.119 0.180 0.036
Polyclonal P 3 0.722 0.667 0.278 0.667 0.667 0.444 0.722 0.611 0.597 0.055
O 34 0.757 0.698 0.653 0.346 0.707 0.597 0.704 0.656 0.640 0.045
All oocysts   131 0.527 0.354 0.436 0.301 0.474 0.406 0.433 0.492 0.428 0.069
  1. Monoclonal and polyclonal infections are defined by initial blood stage results (see main text and Fig. 2)